Effect of a probiotic milk product on gastrointestinal and respiratory infections in children attending day-care

Figures & data

Figure 1.  Disposition of subjects. Most children had several reasons for being excluded from the per-protocol population. PP, per-protocol; ITT, intention-to-treat.

Table I.  Details of symptoms and absence due to symptoms for the intention-to-treat population.

Parameter	Biola	Placebo	p value
Gastrointestinal and/or respiratory symptoms (days)	26.5	26.9	0.52
Gastrointestinal symptoms (days)	1.7	3.0	0.02
Respiratory symptoms (days)	25.4	25.1	0.63
Absence due to illness (days)	7.5	8.5	0.16
Length of periods with symptoms (days)	5.4	4.7	0.88
Number of periods with symptoms	5.4	5.9	0.21